Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Tepilta® Versus Oxetacaine, Antacids and Placebo

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2014 by MEDA Pharma GmbH & Co. KG
Sponsor:
Collaborators:
Trium Analysis Online GmbH
Aptiv Solutions GmbH
Accovion GmbH
Information provided by (Responsible Party):
MEDA Pharma GmbH & Co. KG
ClinicalTrials.gov Identifier:
NCT01336530
First received: April 1, 2011
Last updated: November 19, 2014
Last verified: November 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2016
  Estimated Primary Completion Date: September 2016 (Final data collection date for primary outcome measure)